HK1007432A1 - Purified heparin fractions process for obtaining them and pharmaceutical compositions containing the same - Google Patents

Purified heparin fractions process for obtaining them and pharmaceutical compositions containing the same

Info

Publication number
HK1007432A1
HK1007432A1 HK98106616A HK98106616A HK1007432A1 HK 1007432 A1 HK1007432 A1 HK 1007432A1 HK 98106616 A HK98106616 A HK 98106616A HK 98106616 A HK98106616 A HK 98106616A HK 1007432 A1 HK1007432 A1 HK 1007432A1
Authority
HK
Hong Kong
Prior art keywords
obtaining
same
pharmaceutical compositions
compositions containing
heparin fractions
Prior art date
Application number
HK98106616A
Other languages
English (en)
Inventor
Jean-Francois Branellec
Jose Espejo
Philippe Picart
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9446915&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1007432(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1007432A1 publication Critical patent/HK1007432A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
HK98106616A 1993-05-07 1998-06-25 Purified heparin fractions process for obtaining them and pharmaceutical compositions containing the same HK1007432A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305534A FR2704861B1 (fr) 1993-05-07 1993-05-07 Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
HK1007432A1 true HK1007432A1 (en) 1999-04-09

Family

ID=9446915

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106616A HK1007432A1 (en) 1993-05-07 1998-06-25 Purified heparin fractions process for obtaining them and pharmaceutical compositions containing the same

Country Status (26)

Country Link
US (1) US5599801A (es)
EP (1) EP0623629B1 (es)
JP (1) JP3529835B2 (es)
KR (1) KR100328095B1 (es)
CN (1) CN1066155C (es)
AT (1) ATE141618T1 (es)
AU (1) AU672291B2 (es)
BR (1) BR9401920A (es)
CA (1) CA2122930C (es)
CZ (1) CZ287889B6 (es)
DE (1) DE69400385T2 (es)
DK (1) DK0623629T3 (es)
ES (1) ES2093494T3 (es)
FI (1) FI107388B (es)
FR (1) FR2704861B1 (es)
GR (1) GR3021648T3 (es)
HK (1) HK1007432A1 (es)
HU (1) HU221595B (es)
IL (1) IL109587A (es)
MY (1) MY110862A (es)
NO (1) NO306952B1 (es)
NZ (1) NZ260460A (es)
PL (1) PL178294B1 (es)
RU (1) RU2133253C1 (es)
TW (1) TW438812B (es)
ZA (1) ZA943152B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
EP1109919A2 (en) * 1998-08-27 2001-06-27 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
WO2000065521A2 (en) * 1999-04-23 2000-11-02 Massachusetts Institute Of Technology System and method for polymer notation
JP2003525946A (ja) * 2000-03-08 2003-09-02 マサチューセッツ インスティテュート オブ テクノロジー ヘパリナーゼｉｉｉおよびその使用
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
ES2324701T3 (es) 2000-09-12 2009-08-13 Massachusetts Institute Of Technology Metodos y productos relacionados con heparina de peso molecular bajo.
AU2440802A (en) * 2000-10-18 2002-04-29 Massachusetts Inst Technology Methods and products related to pulmonary delivery of polysaccharides
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
JP2002293804A (ja) * 2001-03-28 2002-10-09 Itoham Foods Inc 低分子量ヘパリンの製造法
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
US8435795B2 (en) * 2010-01-19 2013-05-07 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CA2811186C (en) * 2010-09-14 2018-12-04 Michio Muguruma High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102633905B (zh) * 2011-04-11 2014-10-08 南通天龙畜产品有限公司 一种肝素钠中不被亚硝酸降解且在肝素钠保留时间附近出峰的物质的去除方法
CN104045744B (zh) * 2014-06-26 2016-01-06 常州千红生化制药股份有限公司 达肝素钠的制备方法
CN104098716B (zh) * 2014-07-16 2015-04-22 南京健友生化制药股份有限公司 一种达肝素钠精品的生产方法
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105294885A (zh) * 2015-11-23 2016-02-03 山东大学 一种新来源亚硝酸降解低分子肝素的制备方法
JP2021513593A (ja) * 2018-02-14 2021-05-27 バイオロジカル イー リミテッド ダルテパリンナトリウムを調製する改善された方法
RU186728U1 (ru) * 2018-10-19 2019-01-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" Лабораторное устройство для отмывки порошковых продуктов химических реакций от посторонних примесей
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CA3144968A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides
CN110845641A (zh) * 2019-11-07 2020-02-28 中国药科大学 一种肝素寡糖及其在制备抗血管生成药物中的应用
CN110787489A (zh) * 2019-11-20 2020-02-14 江苏千牧生物科技股份有限公司 一种肝素钠加工使用的分离装置及加工的工艺
CN115304688A (zh) * 2022-08-25 2022-11-08 湖北亿诺瑞生物制药有限公司 一种达肝素钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4438261A (en) * 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
US5094815A (en) * 1988-05-18 1992-03-10 Cornell Research Foundation, Inc. Photolytic interface for HPLC-chemiluminescence detection of non volatile N-nitroso compounds
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia

Also Published As

Publication number Publication date
PL178294B1 (pl) 2000-04-28
FI107388B (fi) 2001-07-31
DE69400385T2 (de) 1996-12-19
JP3529835B2 (ja) 2004-05-24
EP0623629A1 (fr) 1994-11-09
CA2122930A1 (en) 1994-11-08
MY110862A (en) 1999-05-31
CZ287889B6 (cs) 2001-03-14
FR2704861A1 (fr) 1994-11-10
TW438812B (en) 2001-06-07
CN1096034A (zh) 1994-12-07
HU9401446D0 (en) 1994-08-29
CN1066155C (zh) 2001-05-23
ATE141618T1 (de) 1996-09-15
NO306952B1 (no) 2000-01-17
DK0623629T3 (da) 1996-12-23
AU6191294A (en) 1994-11-10
HU221595B (hu) 2002-11-28
CZ113294A3 (en) 1994-12-15
DE69400385D1 (de) 1996-09-26
NZ260460A (en) 1996-02-27
ZA943152B (en) 1995-01-09
HUT70553A (en) 1995-10-30
JPH07126302A (ja) 1995-05-16
EP0623629B1 (fr) 1996-08-21
NO941686L (no) 1994-11-08
FI942095A0 (fi) 1994-05-06
GR3021648T3 (en) 1997-02-28
FR2704861B1 (fr) 1995-07-28
BR9401920A (pt) 1994-11-29
AU672291B2 (en) 1996-09-26
NO941686D0 (no) 1994-05-06
RU94015595A (ru) 1996-09-27
US5599801A (en) 1997-02-04
CA2122930C (en) 2000-10-24
IL109587A0 (en) 1994-08-26
IL109587A (en) 1997-04-15
RU2133253C1 (ru) 1999-07-20
KR100328095B1 (ko) 2002-06-20
ES2093494T3 (es) 1996-12-16
FI942095A (fi) 1994-11-08

Similar Documents

Publication Publication Date Title
GR3021648T3 (en) Purified heparin fractions, process for obtaining them and pharmaceutical compositions containing the same.
HUT67653A (en) Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them
AU5079690A (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis inflammation and as immunosuppressants
GR3023541T3 (en) N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them
DE69315724D1 (de) Polysaccharidderivate von Heparin, Heparansulfate, ihre Fraktionen und Fragmente, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, welche diese enthalten
HUT61554A (en) Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
HUT56492A (en) Process for producing 3-arylcarbonyl-1-aminoalkyl-1h-indole derivatives and pharamceutical compositions comprising such compounds, against glaucoma
AU661591B2 (en) 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
DE69203838T2 (de) Sauerstoff-Absorber und Verfahren zu dessen Herstellung.
EP0659867A3 (de) Verfahren und Vorrichtung zur thermischen Depolymerisation von Kunststoffen.
HUT61466A (en) Process for producing pharmaceutical compositions suitable for treating symptoms of detoxication cures
GB2211845B (en) Process for dechlorinating 4,5-dichlorofluoro-dioxolanes to obtain fluorodioxoles
ATA95690A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ITMI931019A1 (it) Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti
HUT67599A (en) Process for producing dry- processed particles, the produced dry-processed particles, and pharmaceutical compositions containing them
AU3492289A (en) Fluorine-containing copolymer, process for its production and curable composition
EP0626199A3 (en) Process for the production of carbon molecular sieves.
EP0685492A3 (de) Verfahren zur Herstellung molekulareinheitlicher hyperpolymerer Hämoglobine.
ATA252892A (de) Benzofuranylimidazolderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
HU207801B (en) Process for producing pharmaceutical composition for treating psoriasis
AU3555393A (en) Process for the purification of 1,1-dichloro-1-fluoroethane
ITMI913034A1 (it) Metodo per il trattamento chimico di tutte le sostanze organiche con un prodotto atto ad eliminare in modo rapido gli odori da esse emanati e per l'impiego del composto risultante come fertilizzante
MY129219A (en) Stabilization of lacquers
ZA924044B (en) Aminopyrrolidine platinum compounds,process for their production and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20140505